Modeling and therapy of human liver diseases using induced pluripotent stem cells: How far have we come?

Hepatology

Volumn 53, Issue 2, 2011, Pages 708-711

  Soto Gutierrez, Alejandro ^a   Tafaleng, Edgar ^a   Kelly, Victoria ^a   Roy Chowdhury, Jayanta ^b   Fox, Ira J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; CYTOCHROME P450; FUMARYLACETOACETASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL PROLIFERATION; CELL THERAPY; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FAMILIAL HYPERCHOLESTEROLEMIA; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VIVO STUDY; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; METABOLIC DISORDER; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FOLDING;

EID: 79251493316     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24143     Document Type: Article

References (8)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
2. Yamanaka S, Blau HM. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010; 465: 704-712.
3. Rubin LL. Stem cells and drug discovery: the beginning of a new era? Cell 2008; 132: 549-552.
4. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010; 120: 51-59.
5. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, et al. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010; 120: 3127-3136.
6. Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, et al. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010; 120: 3120-3126.
7. Hu BY, Weick JP, Yu J, Ma LX, Zhang XQ, Thomson JA, et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A 2010; 107: 4335-4340.
8. Kulkeaw K, Horio Y, Mizuochi C, Ogawa M, Sugiyama D. Variation in hematopoietic potential of induced pluripotent stem cell lines. Stem Cell Rev 2010; 6: 381-389.